Skip to main content
Premium Trial:

Request an Annual Quote

GVK Biosciences Teams with Indiana CTSI on Biomarker Resource

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GVK Biosciences today said that it has partnered with the Indiana Clinical and Translational Sciences Institute to provide researchers across the US with access to GVK's Clinical Biomarker Database.

According to GVK, the Indiana CTSI Bioinformatics Core and the Indiana Institute for Personalized Medicine will work together to manage the process by which researchers can access the new resource. The database, also known as GOBIOM, is a "comprehensive collection" of biomarkers associated with a variety of therapeutic areas reported in global clinical trials, as well as clinical and preclinical studies.

GOBIOM will be available to researchers at 55 medical centers and universities supported by the Clinical and Translational Sciences Award from the National Institutes of Health.

Hyderabad, India-based GVK noted that the agreement was facilitated by the Indiana Economic Development Corporation during a February economic mission to India.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.